{"id":9106,"date":"2020-03-20T00:15:35","date_gmt":"2020-03-20T08:15:35","guid":{"rendered":"http:\/\/www.drugpolicy.ca\/?p=9106"},"modified":"2020-04-17T08:05:03","modified_gmt":"2020-04-17T16:05:03","slug":"cdsa-exemption-and-interpretive-guide-for-controlled-substances","status":"publish","type":"post","link":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/","title":{"rendered":"CDSA Exemption and Interpretive Guide for Controlled Substances"},"content":{"rendered":"\n<iframe loading=\"lazy\" class=\"scribd_iframe_embed\" title=\"CDSA Exemption and Interpretive Guide for Controlled Substances\" src=\"https:\/\/www.scribd.com\/embeds\/452478109\/content?start_page=1&amp;view_mode=scroll&amp;access_key=key-4UNRNdCAPjecc4xn0lIy\" data-auto-height=\"false\" data-aspect-ratio=\"0.75\" scrolling=\"no\" id=\"doc_93065\" width=\"100%\" height=\"600\" frameborder=\"0\"><\/iframe>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-background is-style-dots\" style=\"background-color:#ffffff;color:#ffffff\"\/>\n\n\n\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link has-background\" href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2020\/03\/CDSA-Exemption-and-interpretive-guide-for-controlled-substances.pdf\" style=\"background-color:#c42127\" target=\"_blank\" rel=\"noreferrer noopener\">Download PDF<\/a><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><p style=\"margin-top:30px\">To maintain Canadians\u2019 access to controlled substances for medical treatments (e.g., treatment of substance use disorders and chronic pain), while they adhere to social distancing guidance from public health officials or if they need to self-isolate, Health Canada has issued the attached exemptions for prescriptions of controlled substances under the Controlled Drugs and Substances Act (CDSA) and its Regulations.<\/p><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If permitted within the applicable provincial\/territorial scopes of practice, the exemptions:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>permit pharmacists to extend prescriptions;<\/li><li>permit pharmacists to transfer prescriptions to other pharmacists;<\/li><li>permit prescribers to issue verbal orders (i.e., over the phone) to extend or refill a prescription; and<\/li><li>permit pharmacy employees to deliver prescriptions of controlled substances to patient\u2019s homes or other locations where they may be (i.e self isolating). <\/li><\/ul>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p style=\"font-size:2.0em; line-height:40px; color:#cc0633\">&#8220;We strongly encourage all partners to work to implement these exemptions in their jurisdictions and welcome any additional suggestions you may have to maintain Canadians\u2019 access to controlled substances for medical reasons during the pandemic.&#8221;<\/p><\/blockquote>\n\n\n<p style=\"color: #cc0633; text-align: right; margin-top: -10px; font-family: faustina;\">~ Health Canada<\/p>\n\n\n<div class=\"widget signup-widget mb-5\">\r\n<p class=\"lead\"><strong>\u00cates-vous pr\u00eat(e) \u00e0 aider ?<\/strong><\/p>\r\n<p>Soutenez des politiques sur les drogues bas\u00e9es sur la justice sociale, la compassion et les preuves. Inscrivez-vous \u00e0 notre newsletter pour obtenir des mises \u00e0 jour et d\u00e9couvrez comment vous pouvez agir avec nous.<\/p>\r\n<!-- form.123formbuilder.com script begins here --><script type=\"text\/javascript\" defer=\"defer\" src=\"https:\/\/form.123formbuilder.com\/embed\/6415583.js\" data-role=\"form\" data-default-width=\"650px\"><\/script><!-- form.123formbuilder.com script ends here -->\r\n<\/div>\r\n","protected":false},"excerpt":{"rendered":"<p>&#8220;We strongly encourage all partners to work to implement these exemptions in their jurisdictions<br \/>\nand welcome any additional suggestions you may have to maintain Canadians\u2019 access to<br \/>\ncontrolled substances for medical reasons during the pandemic.&#8221;<\/p>\n","protected":false},"author":38,"featured_media":9110,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1120],"tags":[1124],"class_list":["post-9106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-research","tag-safe-supply-oat-and-ioat"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CDSA Exemption and Interpretive Guide for Controlled Substances - Canadian Drug Policy Coalition<\/title>\n<meta name=\"description\" content=\"&quot;We strongly encourage all partners to work to implement these exemptions in their jurisdictionsand welcome any additional suggestions you may have to maintain Canadians\u2019 access tocontrolled substances for medical reasons during the pandemic.&quot;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CDSA Exemption and Interpretive Guide for Controlled Substances - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"&quot;We strongly encourage all partners to work to implement these exemptions in their jurisdictionsand welcome any additional suggestions you may have to maintain Canadians\u2019 access tocontrolled substances for medical reasons during the pandemic.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-20T08:15:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-17T16:05:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Capture-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1973\" \/>\n\t<meta property=\"og:image:height\" content=\"1242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Canadian Drug Policy Coalition\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/\"},\"author\":{\"name\":\"Canadian Drug Policy Coalition\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\"},\"headline\":\"CDSA Exemption and Interpretive Guide for Controlled Substances\",\"datePublished\":\"2020-03-20T08:15:35+00:00\",\"dateModified\":\"2020-04-17T16:05:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/\"},\"wordCount\":174,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/Capture-2.jpg\",\"keywords\":[\"safe supply OAT and iOAT\"],\"articleSection\":[\"covid research\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/\",\"name\":\"CDSA Exemption and Interpretive Guide for Controlled Substances - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/Capture-2.jpg\",\"datePublished\":\"2020-03-20T08:15:35+00:00\",\"dateModified\":\"2020-04-17T16:05:03+00:00\",\"description\":\"\\\"We strongly encourage all partners to work to implement these exemptions in their jurisdictionsand welcome any additional suggestions you may have to maintain Canadians\u2019 access tocontrolled substances for medical reasons during the pandemic.\\\"\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/#primaryimage\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/Capture-2.jpg\",\"contentUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/Capture-2.jpg\",\"width\":1973,\"height\":1242},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDSA Exemption and Interpretive Guide for Controlled Substances\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\",\"name\":\"Canadian Drug Policy Coalition\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"caption\":\"Canadian Drug Policy Coalition\"},\"description\":\"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/author\\\/canadian-drug-policy-coalition\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CDSA Exemption and Interpretive Guide for Controlled Substances - Canadian Drug Policy Coalition","description":"\"We strongly encourage all partners to work to implement these exemptions in their jurisdictionsand welcome any additional suggestions you may have to maintain Canadians\u2019 access tocontrolled substances for medical reasons during the pandemic.\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/","og_locale":"fr_FR","og_type":"article","og_title":"CDSA Exemption and Interpretive Guide for Controlled Substances - Canadian Drug Policy Coalition","og_description":"\"We strongly encourage all partners to work to implement these exemptions in their jurisdictionsand welcome any additional suggestions you may have to maintain Canadians\u2019 access tocontrolled substances for medical reasons during the pandemic.\"","og_url":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2020-03-20T08:15:35+00:00","article_modified_time":"2020-04-17T16:05:03+00:00","og_image":[{"width":1973,"height":1242,"url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Capture-2.jpg","type":"image\/jpeg"}],"author":"Canadian Drug Policy Coalition","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Canadian Drug Policy Coalition","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/#article","isPartOf":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/"},"author":{"name":"Canadian Drug Policy Coalition","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30"},"headline":"CDSA Exemption and Interpretive Guide for Controlled Substances","datePublished":"2020-03-20T08:15:35+00:00","dateModified":"2020-04-17T16:05:03+00:00","mainEntityOfPage":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/"},"wordCount":174,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/#primaryimage"},"thumbnailUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Capture-2.jpg","keywords":["safe supply OAT and iOAT"],"articleSection":["covid research"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/","url":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/","name":"CDSA Exemption and Interpretive Guide for Controlled Substances - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/#primaryimage"},"image":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/#primaryimage"},"thumbnailUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Capture-2.jpg","datePublished":"2020-03-20T08:15:35+00:00","dateModified":"2020-04-17T16:05:03+00:00","description":"\"We strongly encourage all partners to work to implement these exemptions in their jurisdictionsand welcome any additional suggestions you may have to maintain Canadians\u2019 access tocontrolled substances for medical reasons during the pandemic.\"","breadcrumb":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/#primaryimage","url":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Capture-2.jpg","contentUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Capture-2.jpg","width":1973,"height":1242},{"@type":"BreadcrumbList","@id":"https:\/\/new.drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"CDSA Exemption and Interpretive Guide for Controlled Substances"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30","name":"Canadian Drug Policy Coalition","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","caption":"Canadian Drug Policy Coalition"},"description":"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice","url":"https:\/\/new.drugpolicy.ca\/fr\/author\/canadian-drug-policy-coalition\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/9106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=9106"}],"version-history":[{"count":7,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/9106\/revisions"}],"predecessor-version":[{"id":9118,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/9106\/revisions\/9118"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/9110"}],"wp:attachment":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=9106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=9106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=9106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}